MORGAN STANLEY

Holdings History for Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD)

Symbol: LUCD on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$111,832	102,598	+4,899	+5%	$1.09	Q4 2025
30 Sep 2025	0%	-0%	$98,676	97,699	-368,931	-79%	$1.01	Q3 2025
30 Jun 2025	0%	+0%	$536,624	466,630	+355,040	+318%	$1.15	Q2 2025
31 Mar 2025	0%	+0%	$166,269	111,590	+56,996	+100%	$1.49	Q1 2025
31 Dec 2024	0%	+0%	$44,696	54,594	+54,200	+13700%	$0.82	Q4 2024
30 Sep 2024	0%	0%	$321	394	-560		$0.81	Q3 2024
30 Jun 2024	0%	0%	$782	954	-22		$0.82	Q2 2024
31 Mar 2024	0%	0%	$790	976	+776	+388%	$0.81	Q1 2024
31 Dec 2023	0%	0%	$282	200	0		$1.41	Q4 2023
30 Sep 2023	0%	0%	$234	200	0		$1.17	Q3 2023
30 Jun 2023	0%	0%	$278	200	-600	-75%	$1.39	Q2 2023
31 Mar 2023	0%	0%	$1,120	800	-93	-10%	$1.40	Q1 2023
31 Dec 2022	0%	-0%	$1,214	893	-17,878	-95%	$1.36	Q4 2022
30 Sep 2022		0%	$1,000	390	0		$2.56 ^*	Q3 2022
30 Sep 2022	0%	-0%	$29,000	18,771	-39,096	-68%	$1.54	Q3 2022
30 Jun 2022	0%	+0%	$131,000	57,867	+48,725	+533%	$2.26	Q2 2022
31 Mar 2022	0%	-0%	$31,000	9,142	-12,620	-58%	$3.39	Q1 2022
31 Dec 2021	0%	+0%	$116,000	21,762	+21,762	NEW	$5.33	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.